Tien Hsien Liquid Scientific Study — FRC Research Project

Study of the Inhibitory Effect of Tien Hsien Liquid on Metastatic S180 Sarcoma and Liver Cancer
By testing Tien Hsien Liquid on S180 sarcoma and liver cancer, it has been confirmed that Tien Hsien Liquid does have inhibitory effect on tumor cells.

Research Content

  1. 7-9 days after intra-abdominal implantation of the S180 sarcoma cell-line into rodents, the peritoneal fluid was extracted and diluted with saline water and injected subcutaneously into the rodents right axilla. After separating into four groups, three were set to be the experimental groups and the rodents in these groups were fed with either high, mid or low dose of Tien Hsien Liquid; the other was set to be the control group without feeding Tien Hsien Liquid. Dissection was done after 13 days to accurately measure the tumor weight.

  2. After diluting the liver cancer cell-line with saline water, 0.2ml of cancer cell suspension was injected into the rodents’ axilla. After separating into groups, the rodents in the experimental group were fed with Tien Hsien Liquid daily and were dissected on day 9 to accurately measure the body weight and liver cancer mass.

Result
The inhibition rate of Tien Hsien Liquid on S180 sarocoma for the high, mid and low dose were 59.73%, 52.57%, and 41.33% respectively. The inhibiton rate for liver cancer was 47.81%.

When comparing the average cancer weight of the tumors of the treatment group to those of the control group, the lesions were significantly smaller and the average weight was lighter for the Tien Hsien Liquid group, this indicates that Tien Hsien Liquid is an anti-cancer drug that is based on Chinese Medicine; and its inhibition of S180 sarcoma and liver cancer is not only effective but also backed by scientific data.

 

Other FRC Research Project

  1. Toxicology Study

  2. Comprehensive Research Report on Tien Hsien Liquid's Ability to Remove Free-Radicals

  3. Study of the Inhibitory Effect of Tien Hsien Liquid on Metastatic S180 Sarcoma and Liver Cancer

  4. Study of the Effects on Non-Specific Immunity in Rodents